We provide comprehensive hematology care to patients with all types of hematological diseases, from benign to malignant, and from hereditary to acquired.

Below is a summary of the more common types of diseases we treat, although it is not comprehensive, since a complete list would be beyond the scope of this site.

1. Anemias: iron deficiency, B12 or folic acid deficiency, thalassemia trait (or thalassemia intermedia or major), anemia of chronic disorders, sideroblastic anemia. Hemolytic anemias, including G6PD deficiency, hereditary spherocytosis, immune hemolytic anemias, PNH. Abnormal hemoglobins, such as sickle cell anemia, unstable hemoglobins, other hemoglobinopathies, such as sickle cell disease, Hb SC, Hemoglobin O-Arab, Hemoglobin Lepore. Anemia is the most common hematological problem and may be multifactorial, and therefore can be complicated to treat and diagnose. We would be happy to have you see one of our general hematologists for help with diagnosis and therapy (Prof Deborah Rund, Dr. Ada Goldfarb, Dr. Orly Zelig).

2. Excess of red blood cells (polycythemia) or excess of other blood elements: These conditions can be caused by many problems and needs to be evaluated by one of our general hematologists for achieving a specific diagnosis and selecting appropriate therapy. These diseases include chronic leukemias, thrombocytosis, and myelofibrosis. Depending on the type of disease, one of our general hematologists should be consulted (Prof. Deborah Rund, Dr. Ada Goldfarb, Dr. Orly Zelig). Patients with CML (chronic myeloid leukemia) should consult Prof. Dina Ben-Yehuda, who is an expert in treating this disease.

3. Clotting disorders: This includes many types of conditions, including too few or too many platelets (ITP or essential thrombocytosis), platelet function problems (which may be mild and difficult to diagnose and can be hereditary or acquired).
In addition, many types of coagulation problems can be diagnosed, including abnormalities of the PT and the PTT (due to hereditary or acquired deficiencies of clotting factors). Besides bleeding disorders, hypercoagulability evaluation is an increasingly important part of a hematological evaluation. All of these problems can be approached with Prof. David Varon, our coagulation specialist, in his Coagulation Clinic twice weekly.

4. Malignant diseases: These include Lymphomas, including Hodgkin's disease and Non Hodgkin's lymphoma. There are several dozen types of nonHodgkin's lymphoma, and each has its own diagnostic and prognostic parameters. In addition, there are many types of leukemias including some chronic leukemias such as CLL (chronic lymphocytic leukemia), CML (chronic myeloid leukemia), or Hairy cell leukmia (HCL).  In addition, there are acute leukemias such as acute lymphocytic leukemia (ALL), and acute myeloid leukemia (AML). In addition, there are diseases of plasma cells, such as plasmacytomas, multiple myeloma and Waldenstrom's Macroglobulinemia. All of our hematologists (except Prof. Varon) are skilled in caring for and evaluating patients with hematological malignancies. In particular, Dr. Ora Paltiel and Prof. Polliack assess lymphoma patients in Lymphoma Clinic. Prof. Ben Yehuda also sees many lymphoma patients in her outpatient clinic.

For additional information on the hematological diseases, there are a number of web sites with information which can be of interest to our patients. Some of these are general and some a specific to a particular disease.

1) Information on Thalassemia: www.Thalassemia.com.

2) Information on Hematological Diseases:
www.focusoncancer.com;
www.cancer.gov;
www.cmlhelp.org;
www.cancerbacup.org.uk/info;
www.patientcenters.com/lymphoma; www.icrf.org/aboutcancer/specificcancers;
www.lymphomainfo.net;
www.viahealth.org/disease/blood/sitemap.htm

3) Information on Bleeding Disorders:
http://seconde.scripps.edu/itp;
www.itppeople.com/aboutitp.htm;
www.hemophilia.org/bdi/bdi/htm